Frontlight ResearchEarly access
Trial site
Antoni van Leeuwenhoek Ziekenhuis
- 5running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer5 trials
- Lung cancer3 trials
- Colorectal cancer2 trials
- Melanoma2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Neuroendocrine tumours1 trial
- Prostate cancer1 trial
- Thyroid cancer1 trial
- and 1 more
- Phase
- Phase 14 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 32 trials
- Phase 41 trial
- Status
- Completed7 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- The Netherlands Cancer Institute5 trials
- Comprehensive Cancer Centre The Netherlands1 trial
- Daiichi Sankyo Inc.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Genentech, Inc.1 trial
- and 3 more
Running trials
Not yet recruiting
Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC
Recruiting
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Recruiting
Recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Pre-operative Immunotherapy in Stage II-III Urothelial Cancer
Completed
Completed
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer
Completed
Completed
Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026